This page shows the latest Sofinnova Partners news and features for those working in and with pharma, biotech and healthcare.
Ashrafian, a partner at SV Health Investors, which co-led the Series A with Sofinnova Partners.
Cambridge is of course also where Illumina was carrying out the DNA sequencing for the UK’s 100, 000 Genomes Project, in collaboration with Genomics England and other partners such as ... Illumina is joining forces with several venture firms for the
The fundraising was co-led by leading healthcare investors Sofinnova Partners and 5AM Ventures, with Epidarex Capital and F-Prime Capital Partners also taking part.
Its investors are Andera Partners (via Europe’s largest life sciences fund Biodiscovery V) and new backers, China’s Quan, plus existing investors Sofinnova Partners, IP Group, EMBL and Takeda Ventures.
Sofinnova Partners, a French investment firm, led the Series A round, joined by additional backers Norway-based NeoMed Management and Bostonís MVM Life Science Partners. ... The lead investor was Special Situations Fund, while other investors were Fort
Ablynx has raised over EUR 70 million (GBP 46.9 million) from an investor consortium which includes Abingworth Management (UK), Alta Partners (US), Biotech Fund Flanders (Belgium), Gilde Investment Management (Netherlands), ... GIMV (Belgium), KBC
More from news
Approximately 0 fully matching, plus 6 partially matching documents found.
Rothman brings 40 years of experience along with an international network in the medical field to Sofinnova Partners. ... Rothman said: “I am thrilled to join Sofinnova Partners’ team as venture partner.
Prior to his involvement with Fovea, Dr Gilly was a venture partner with Sofinnova Partners from 2000 to 2005.
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...